Nevada · Senate Bill 354 · 83rd (2025) Session

Revises provisions relating to health insurance coverage of prescription drugs. (BDR 57-1041)

  1. Introduced Mar 13, 2025
  2. In committee Mar 13, 2025
  3. Died  
  4. Passed the Assembly  
  5. To the governor  
  6. Became law  

What it does

The legislature's own summary of the bill, or its official long title.

Existing law requires certain public and private health plans, including the Public Employees' Benefits Program, to cover: (1) drugs that prevent the acquisition of human immunodeficiency virus or that treat human immunodeficiency virus or hepatitis C; (2) related laboratory and diagnostic procedures; and (3) certain other services to test for, prevent or treat human immunodeficiency virus or hepatitis C. (NRS…

Read the full title (188 words)

Existing law requires certain public and private health plans, including the Public Employees' Benefits Program, to cover: (1) drugs that prevent the acquisition of human immunodeficiency virus or that treat human immunodeficiency virus or hepatitis C; (2) related laboratory and diagnostic procedures; and (3) certain other services to test for, prevent or treat human immunodeficiency virus or hepatitis C. (NRS 287.04335, 689A.0437, 689B.0312, 689C.1671, 695A.1843, 695B.1924, 695C.050, 695C.1743, 695G.1705) Existing law prohibits such health plans from implementing any medical management techniques on the coverage of such drugs or services, except the use of step therapy. (NRS 287.010, 287.04335, 689A.0437, 689B.0312, 689C.1671, 695A.1843, 695B.1924, 695C.050, 695C.1743, 695G.1705) Sections 1-7 of this bill remove the exemption for step therapy for private health plans, thereby prohibiting such health plans from requiring step therapy before providing coverage for a drug that: (1) prevents the acquisition of human immunodeficiency virus; or (2) treats human immunodeficiency virus or hepatitis C. Sections 6-8.5 of this bill authorize the Public Employees' Benefits Program and Medicaid managed care organizations to continue requiring the use of step therapy for coverage of such drugs as a medical management technique.

Every action

21 steps, oldest first, as the legislature records them.

Show the 13 earlier steps
  1. SenateRead first time.
  2. CommitteeReferred to Committee on Commerce and Labor. · Senate Commerce and Labor
  3. SenateTo printer.
  4. SenateFrom printer.
  5. SenateTo committee.
  6. CommitteeFrom committee: Amend, and do pass as amended. · Senate Commerce and Labor
  7. SenatePlaced on Second Reading File.
  8. SenateRead second time.
  9. SenateAmended. (Amend. No. 315.)
  10. SenateReprinting dispensed with.
  11. SenateNotice of eligibility for exemption.
  12. SenateTaken from General File.
  13. CommitteeRe-referred to Committee on Finance. · Senate Finance
  1. SenateExemption effective.
  2. SenateTo printer.
  3. SenateFrom printer.
  4. SenateTo engrossment.
  5. SenateEngrossed.
  6. SenateFirst reprint.
  7. SenateTo committee.
  8. Senate(No further action taken.)

Roll calls

No recorded votes on this bill yet.

Sponsors

The member who introduced it, joined by 3 cosponsors: 2 Democrats, 1 Republican.

All 3 cosponsors

From Nevada's official records (leg.state.nv.us), checked Nov 13, 2026. Text links go to the official versions; LegiList does not copy bill text.